ZA995201B - Stabilized protein compositions. - Google Patents

Stabilized protein compositions.

Info

Publication number: ZA995201B
Authority: ZA; South Africa
Prior art keywords: protein compositions; stabilized protein; stabilized; compositions; protein
Prior art date: 1998-08-17

Application number

ZA9905201A

Other languages

English (en)

Inventor

Peter Connor Canning

Barbara Jean Kamicker

Kasra Kasrain

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-17

Filing date

1999-08-16

Publication date

2001-02-16

1999-08-16 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-02-16 Publication of ZA995201B publication Critical patent/ZA995201B/xx

Links

239000000203 mixture Substances 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Dermatology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

ZA9905201A 1998-08-17 1999-08-16 Stabilized protein compositions. ZA995201B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9687698P	1998-08-17	1998-08-17

Publications (1)

Publication Number	Publication Date
ZA995201B true ZA995201B (en)	2001-02-16

Family

ID=22259521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9905201A ZA995201B (en)	1998-08-17	1999-08-16	Stabilized protein compositions.

Country Status (16)

Country	Link
US (1)	US20050232898A1 (de)
EP (1)	EP0988861B1 (de)
JP (1)	JP3641170B2 (de)
CN (1)	CN1250282C (de)
AR (1)	AR016504A1 (de)
AT (1)	ATE260674T1 (de)
AU (2)	AU767431B2 (de)
BR (1)	BR9904150A (de)
CA (1)	CA2280449A1 (de)
DE (1)	DE69915204T2 (de)
DK (1)	DK0988861T3 (de)
ES (1)	ES2216447T3 (de)
NZ (2)	NZ510140A (de)
PT (1)	PT988861E (de)
TW (1)	TWI221773B (de)
ZA (1)	ZA995201B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1129720B1 (de) *	2000-02-29	2004-06-23	Pfizer Products Inc.	Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
JP5052736B2 (ja) *	2001-05-30	2012-10-17	中外製薬株式会社	タンパク質製剤
ITMI20021684A1 (it) *	2002-07-29	2004-01-29	Therapicon Srl	Composizione farmaceutica di peptide nasale
ITBA20020032A1 (it) *	2002-09-24	2004-03-25	Bio D Soc	Metodo per stabilizzare le proteine per la conservazione ad alte temperature.
WO2005025593A2 (en) *	2003-05-09	2005-03-24	Schering Aktiengesellschaft	Treatment of inflammatory respiratory diseases
CN1878570B (zh) *	2003-11-04	2010-10-06	力奇制药公司	包含粒细胞集落形成刺激因子的稳定的药物组合物
EP1537876A1 (de) *	2003-12-01	2005-06-08	BioGeneriX AG	Formulierung einer Erythropoietin Lösung
US20050124702A1 (en) *	2003-12-09	2005-06-09	Alcon, Inc.	Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions
MX2007005521A (es) *	2004-11-12	2007-05-18	Novo Nordisk As	Formulaciones estables de peptidos insulinotropicos.
ES2383303T3 (es) *	2005-11-10	2012-06-20	Chemi S.P.A.	Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
DE202006020194U1 (de)	2006-03-01	2007-12-06	Bioceuticals Arzneimittel Ag	G-CSF-Flüssigformulierung
EP2094247B1 (de)	2006-10-20	2022-06-29	Amgen Inc.	Stabile polypeptid-formulierungen
MX2010002348A (es)	2007-08-27	2010-07-30	Biogenerix Ag	Formulacion liquida de g-csf.
CA2701918C (en) *	2007-10-09	2014-08-05	Hercules Incorporated	Crosslinkercontaining adhesive compositions
CN102159230A (zh) *	2008-07-23	2011-08-17	Ambrx公司	经修饰的牛g-csf多肽和其用途
TWI480288B (zh) *	2010-09-23	2015-04-11	Lilly Co Eli	牛顆粒細胞群落刺激因子及其變體之調配物
ITMI20120338A1 (it) *	2012-03-06	2013-09-07	Dr Andrea Bignotti	Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
GB2516808A (en)	2013-05-31	2015-02-11	Innova Biosciences Ltd	Antibody composition and buffer system therefor
US10500253B2 (en)	2015-01-05	2019-12-10	Cornell University	Compositions and methods using IL-8 to improve milk production and reproductive health in mammals
US11464831B2 (en)	2015-01-05	2022-10-11	Cornell University	Compositions and methods using IL-8 for improving health of mammals
EP3554257B1 (de)	2016-12-15	2023-07-12	Société des Produits Nestlé S.A.	Zusammensetzungen und verfahren zur modulation von weissen blutkörperchen oder neutrophilen in einem haustier
EP3771463A1 (de)	2019-07-29	2021-02-03	Ludwig-Maximilians-Universität München	Stabilisierung therapeutischer proteine mit piperazin- oder morpholinhaltigen zwitterionischen puffersubstanzen
CN116836920B (zh) *	2023-08-21	2024-05-24	广东横琴粤澳深度合作区齐美国际干细胞医院有限公司	一种无血清培养基及其制备间充质干细胞的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0080879B1 (de) *	1981-11-28	1986-10-01	Sunstar Kabushiki Kaisha	Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung
JPS6069037A (ja) *	1983-09-26	1985-04-19	Sunstar Inc	エリテマト−デス治療用外用剤
US4605555A (en) *	1984-09-20	1986-08-12	Sun Star Kabushiki Kaisha	Composition and method for treating keratosic disorder of skin and mucosa
JPH0618781B2 (ja) *	1986-10-18	1994-03-16	中外製薬株式会社	感染症治療剤
KR0133561B1 (ko) *	1988-05-13	1998-04-21	스티븐 엠. 오드레	과립구 군체 자극인자의 정제방법
US5013714A (en) *	1988-12-15	1991-05-07	Lindstrom Richard L	Viscoelastic solution
US6066469A (en) *	1990-03-08	2000-05-23	Ferro Dynamics, Inc.	Cloning, expression, and uses of human lactoferrin
DE4242919A1 (de) *	1992-12-18	1994-06-23	Boehringer Mannheim Gmbh	Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
US5580856A (en) *	1994-07-15	1996-12-03	Prestrelski; Steven J.	Formulation of a reconstituted protein, and method and kit for the production thereof

1999
- 1999-08-06 AT AT99306262T patent/ATE260674T1/de not_active IP Right Cessation
- 1999-08-06 PT PT99306262T patent/PT988861E/pt unknown
- 1999-08-06 DK DK99306262T patent/DK0988861T3/da active
- 1999-08-06 DE DE69915204T patent/DE69915204T2/de not_active Expired - Fee Related
- 1999-08-06 EP EP99306262A patent/EP0988861B1/de not_active Expired - Lifetime
- 1999-08-06 ES ES99306262T patent/ES2216447T3/es not_active Expired - Lifetime
- 1999-08-11 TW TW088113760A patent/TWI221773B/zh not_active IP Right Cessation
- 1999-08-13 CA CA002280449A patent/CA2280449A1/en not_active Abandoned
- 1999-08-13 AR ARP990104080A patent/AR016504A1/es active IP Right Grant
- 1999-08-16 AU AU44501/99A patent/AU767431B2/en not_active Ceased
- 1999-08-16 ZA ZA9905201A patent/ZA995201B/xx unknown
- 1999-08-16 NZ NZ510140A patent/NZ510140A/en unknown
- 1999-08-16 NZ NZ337258A patent/NZ337258A/en unknown
- 1999-08-17 JP JP23085399A patent/JP3641170B2/ja not_active Expired - Fee Related
- 1999-08-17 BR BR9904150-2A patent/BR9904150A/pt not_active Application Discontinuation
- 1999-08-17 CN CNB99122020XA patent/CN1250282C/zh not_active Expired - Fee Related
2004
- 2004-02-13 AU AU2004200568A patent/AU2004200568A1/en not_active Abandoned
2005
- 2005-06-01 US US11/143,340 patent/US20050232898A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NZ337258A (en)	2001-04-27
CA2280449A1 (en)	2000-02-17
EP0988861B1 (de)	2004-03-03
EP0988861A1 (de)	2000-03-29
AR016504A1 (es)	2001-07-04
AU2004200568A1 (en)	2004-03-11
AU4450199A (en)	2000-03-09
DE69915204T2 (de)	2004-07-29
HK1026151A1 (en)	2000-12-08
ES2216447T3 (es)	2004-10-16
CN1250282C (zh)	2006-04-12
AU767431B2 (en)	2003-11-13
CN1250668A (zh)	2000-04-19
BR9904150A (pt)	2000-12-26
ATE260674T1 (de)	2004-03-15
JP2000063264A (ja)	2000-02-29
DK0988861T3 (da)	2004-04-19
JP3641170B2 (ja)	2005-04-20
PT988861E (pt)	2004-06-30
DE69915204D1 (de)	2004-04-08
US20050232898A1 (en)	2005-10-20
TWI221773B (en)	2004-10-11
NZ510140A (en)	2005-01-28

Publication	Publication Date	Title
ZA200005478B (en)	2001-10-08	Shampoo compositions.
ZA984849B (en)	1999-12-06	Compositions.
ZA995201B (en)	2001-02-16	Stabilized protein compositions.
ZA991014B (en)	1999-08-10	Pesticidal compositions.
EP1113799A4 (de)	2004-06-09	Proteinformulierung
ZA996185B (en)	2000-04-10	Sulfanylsilanes.
ZA200005136B (en)	2001-03-02	Dihydropyrimides.
ZA200003283B (en)	2001-01-18	Topical compositions containing whey proteins.
AP2000001874A0 (en)	2000-09-30	Cellecoxib compositions
ZA987536B (en)	2000-02-21	Stanol comprising compositions.
ZA991272B (en)	1999-08-18	Novel thiobenzamides.
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
ZA993197B (en)	1999-11-10	Pesticidal composition.
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
ZA995325B (en)	2000-02-22	Methylcyclotetradec-5-en-1-ones.
ZA995239B (en)	2000-02-21	Pesticidal compositions.
PL344979A1 (en)	2001-11-19	Angiostatin-binding protein
ZA200006118B (en)	2002-01-30	Novel composition.
ZA99677B (en)	1999-09-02	Placental protein 13.
ZA992214B (en)	1999-09-20	Oligomeric stabilizer mixture.
ZA99890B (en)	2000-08-04	Pharmaceutical compositions.
ZA991892B (en)	2000-02-07	Herbicidal compositions.
GB9803399D0 (en)	1998-04-15	Protein kinase c
ZA992066B (en)	2000-10-11	Liner compositions.
GB0016470D0 (en)	2000-08-23	Compositions